The US Drug Enforcement Administration is currently accepting comments from the public on whether to reclassify cannabis via the Federal eRulemaking Portal.
The amendment targets products containing cannabinoids that "are not capable of being naturally produced" by the hemp plant or that are the result of a chemical synthesis.